Voss Funds disclose 699,440 and 316,768 shares in RNTX
Rhea-AI Filing Summary
Voss-affiliated investors reported initial beneficial ownership in Rein Therapeutics, Inc. (RNTX). The Form 3, covering an event dated 09/24/2025 and filed on 10/03/2025, shows the filing group collectively beneficially owns over 10% of Rein Therapeutics common stock. The filing lists Voss Value Master Fund, LP with 699,440 shares and Voss Value-Oriented Special Situations Fund, LP with 316,768 shares, held indirectly through Voss Advisors GP, LLC, Voss Capital, LP and Travis W. Cocke. The report is a joint Form 3 by multiple Voss entities and Mr. Cocke and disclaims ownership beyond pecuniary interest.
Positive
- Group reported collective beneficial ownership of over 10%
- Voss Value Master Fund directly holds 699,440 shares
- Voss Value-Oriented Special Situations Fund directly holds 316,768 shares
- Form 3 filed jointly and signed by Travis W. Cocke on 10/03/2025
Negative
- None.
Insights
Voss group disclosed a >10% passive ownership stake in RNTX, signaling an influential shareholder presence.
What it means: The filing identifies a group of affiliated entities and an individual—Voss Value Master Fund, LP, Voss Value-Oriented Special Situations Fund, LP, Voss Advisors GP, LLC, Voss Capital, LP, and Travis W. Cocke—that together beneficially own over 10% of Rein Therapeutics.
Why it matters: Crossing the 10% threshold is a regulatory disclosure trigger and signals a shareholder with potential voting influence or interest in engagement. The Form 3 shows specific share counts of 699,440 and 316,768 held by two funds, which establishes the factual baseline for the groups stake without indicating any additional actions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock, $0.001 par value | -- | -- | -- |
| holding | Common Stock, $0.001 par value | -- | -- | -- |
Footnotes (3)
- F1. This Form 3 is filed jointly by Voss Value Master Fund, LP ("Voss Value Master Fund"), Voss Value-Oriented Special Situations Fund, LP ("Voss Value-Oriented Special Situations Fund"), Voss Advisors GP, LLC ("Voss GP"), Voss Capital, LP ("Voss Capital") and Travis W. Cocke (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F2. Securities owned directly by Voss Value Master Fund. Voss GP, as the general partner of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Voss Capital, as the investment manager of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund.
- F3. Securities owned directly by Voss Value-Oriented Special Situations Fund. Voss GP, as the general partner of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Voss Capital, as the investment manager of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund.
AI-generated analysis. How Rhea-AI works. Not financial advice.